^
Association details:
| Biomarker: | MYD88 overexpression |
|---|---|
| Cancer: | Squamous Cell Carcinoma of Head and Neck |
| Drug: | Erbitux (cetuximab) (EGFR inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Published date:
03/21/2020
Excerpt:
MyD88 overexpressed SCC4 cells grew faster and were almost resistant to cetuximab therapy.
